<DOC>
	<DOCNO>NCT00004759</DOCNO>
	<brief_summary>OBJECTIVES : I . Compare efficacy safety 24- versus 48-hour infusion methylprednisolone ( MePRDL ) versus tirilazad patient acute spinal cord injury . II . Compare neurologic recovery follow 24- 48-hour MePRDL infusion .</brief_summary>
	<brief_title>Methylprednisolone Given 24-Hour 48-Hour Infusion Versus Tirilazad Acute Spinal Cord Injury</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This randomize , double-blind study . Patients stratify participate institution . Patients randomly assign 1 3 treatment group within 6 hour injury . Treatment begin within 2 hour randomization . One group receive 24-hour methylprednisolone ( MePRDL ) infusion : loading dose follow 45 minute 23-hour continuous infusion . A placebo tirilazad also administer . A second group receive MePRDL load dose continuous infusion maintain 48 hour . A placebo tirilazad also administer . A third group receive 48-hour infusion tirilazad initial bolus dose MePRDL . Eight additional dos tirilazad administer intravenous push . The MePRDL load dose may omit patient receive prestudy MePRDL dose . Patients follow 72 hour , 6 week , 6 month , 1 year injury .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<mesh_term>Tirilazad</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Acute spinal cord injury ; diagnosis confirm study physician use National Acute Spinal Cord Injury Study neurologic exam Glasgow Coma Score great 9 Randomization within 6 hour injury require ; treatment must begin within 8 hour injury No root involvement ; cauda equina Prior/Concurrent Therapy Methylprednisolone bolus ( 2040 mg/kg ) prior hospital admission allow Patient Characteristics Hematopoietic : No hematologic contraindication protocol therapy Cardiovascular : No vascular contraindication protocol therapy Other : No diabetes ; No gunshot wound ; No gastrointestinal bleeding ; No lifethreatening comorbidity ; No medical contraindication protocol therapy ; No pregnant woman ; No patient indictment incarcerate ; No condition would complicate followup , e.g . : outofstate residency illegal alien status</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>environmental/toxic disorder</keyword>
	<keyword>neurologic psychiatric disorder</keyword>
	<keyword>rare disease</keyword>
	<keyword>spinal cord injury</keyword>
</DOC>